147 related articles for article (PubMed ID: 16407827)
21. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.
Rozakis-Adcock M; Fernley R; Wade J; Pawson T; Bowtell D
Nature; 1993 May; 363(6424):83-5. PubMed ID: 8479540
[TBL] [Abstract][Full Text] [Related]
22. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.
Najib S; Sánchez-Margalet V
J Cell Biochem; 2002; 86(1):99-106. PubMed ID: 12112020
[TBL] [Abstract][Full Text] [Related]
23. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
24. Phospholipase D2-derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR.
Lehman N; Ledford B; Di Fulvio M; Frondorf K; McPhail LC; Gomez-Cambronero J
FASEB J; 2007 Apr; 21(4):1075-87. PubMed ID: 17242159
[TBL] [Abstract][Full Text] [Related]
25. The Lipase Activity of Phospholipase D2 is Responsible for Nigral Neurodegeneration in a Rat Model of Parkinson's Disease.
Mendez-Gomez HR; Singh J; Meyers C; Chen W; Gorbatyuk OS; Muzyczka N
Neuroscience; 2018 May; 377():174-183. PubMed ID: 29526688
[TBL] [Abstract][Full Text] [Related]
26. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
27. Identification of a second Grb2 binding site in the v-Fms tyrosine kinase.
Mancini A; Niedenthal R; Joos H; Koch A; Trouliaris S; Niemann H; Tamura T
Oncogene; 1997 Sep; 15(13):1565-72. PubMed ID: 9380408
[TBL] [Abstract][Full Text] [Related]
28. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.
Hanafusa H; Torii S; Yasunaga T; Nishida E
Nat Cell Biol; 2002 Nov; 4(11):850-8. PubMed ID: 12402043
[TBL] [Abstract][Full Text] [Related]
29. Two sites of action for PLD2 inhibitors: The enzyme catalytic center and an allosteric, phosphoinositide biding pocket.
Ganesan R; Mahankali M; Alter G; Gomez-Cambronero J
Biochim Biophys Acta; 2015 Mar; 1851(3):261-72. PubMed ID: 25532944
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase Cdelta-mediated phosphorylation of phospholipase D controls integrin-mediated cell spreading.
Chae YC; Kim KL; Ha SH; Kim J; Suh PG; Ryu SH
Mol Cell Biol; 2010 Nov; 30(21):5086-98. PubMed ID: 20733000
[TBL] [Abstract][Full Text] [Related]
31. Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos.
Zhao C; Du G; Skowronek K; Frohman MA; Bar-Sagi D
Nat Cell Biol; 2007 Jun; 9(6):706-12. PubMed ID: 17486115
[TBL] [Abstract][Full Text] [Related]
32. Cdk5 phosphorylates PLD2 to mediate EGF-dependent insulin secretion.
Lee HY; Jung H; Jang IH; Suh PG; Ryu SH
Cell Signal; 2008 Oct; 20(10):1787-94. PubMed ID: 18625302
[TBL] [Abstract][Full Text] [Related]
33. New concepts in phospholipase D signaling in inflammation and cancer.
Gomez-Cambronero J
ScientificWorldJournal; 2010 Jul; 10():1356-69. PubMed ID: 20623096
[TBL] [Abstract][Full Text] [Related]
34. Identification of the catalytic site of phospholipase D2 (PLD2) newly described guanine nucleotide exchange factor activity.
Mahankali M; Henkels KM; Alter G; Gomez-Cambronero J
J Biol Chem; 2012 Nov; 287(49):41417-31. PubMed ID: 23035122
[TBL] [Abstract][Full Text] [Related]
35. Evidence for two CRIB domains in phospholipase D2 (PLD2) that the enzyme uses to specifically bind to the small GTPase Rac2.
Peng HJ; Henkels KM; Mahankali M; Dinauer MC; Gomez-Cambronero J
J Biol Chem; 2011 May; 286(18):16308-20. PubMed ID: 21378159
[TBL] [Abstract][Full Text] [Related]
36. Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity.
Tong J; Elowe S; Nash P; Pawson T
J Biol Chem; 2003 Feb; 278(8):6111-9. PubMed ID: 12486127
[TBL] [Abstract][Full Text] [Related]
37. Phospholipase D2 directly interacts with aldolase via Its PH domain.
Kim JH; Lee S; Kim JH; Lee TG; Hirata M; Suh PG; Ryu SH
Biochemistry; 2002 Mar; 41(10):3414-21. PubMed ID: 11876650
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of enzymatic reaction and protein-protein interactions of PLD from a 3D structural model.
Mahankali M; Alter G; Gomez-Cambronero J
Cell Signal; 2015 Jan; 27(1):69-81. PubMed ID: 25308783
[TBL] [Abstract][Full Text] [Related]
39. PLD2 complexes with the EGF receptor and undergoes tyrosine phosphorylation at a single site upon agonist stimulation.
Slaaby R; Jensen T; Hansen HS; Frohman MA; Seedorf K
J Biol Chem; 1998 Dec; 273(50):33722-7. PubMed ID: 9837959
[TBL] [Abstract][Full Text] [Related]
40. Phospholipase D2 is a positive regulator of sirtuin 1 and modulates p53-mediated apoptosis via sirtuin 1.
Lee H; Jung TY; Lim SH; Choi EJ; Lee J; Min DS
Exp Mol Med; 2021 Sep; 53(9):1287-1297. PubMed ID: 34471223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
